Prescribing Red Flags: Pharmacists Be Wary of What the Doctor Orders
FDA Law Blog: Biosimilars
MAY 19, 2025
By Larry K. Houck Last month the U.S. Attorneys Office for the Northern District of Illinois announced that Walgreens agreed to pay up to $350,000,000 to resolve allegations that its pharmacies illegally filled millions of invalid prescriptions for opioids and other controlled substances in violation of the federal Controlled Substances Act, and sought payment for filling many of those prescriptions by federal health care programs, violating the False Claims Act.
Let's personalize your content